Public Sector Pension Investment Board (PSP Investments)’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-32,587
Closed -$365K 1517
2017
Q3
$365K Buy
32,587
+6,087
+23% +$67.1K ﹤0.01% 1248
2017
Q2
$292K Sell
26,500
-8,000
-23% -$80K ﹤0.01% 1181
2017
Q1
$338K Hold
34,500
﹤0.01% 1192
2016
Q4
$373K Hold
34,500
﹤0.01% 1176
2016
Q3
$354K Hold
34,500
﹤0.01% 1147
2016
Q2
$451K Buy
+34,500
New +$452K 0.01% 1070

Public Sector Pension Investment Board (PSP Investments)'s SCLN Position: Q4 2017 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 32,587 shares — an estimated $365K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $451K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 32,587 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $365K.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Sciclone Pharmaceuticals Inc position peaked at $451K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q4 2017, filed 2 Feb 2018.